Effects of vericiguat in heart failure with reduced ejection fraction: do not forget sST2. Reply

Eur J Heart Fail. 2020 Oct;22(10):1935. doi: 10.1002/ejhf.1765. Epub 2020 Feb 21.

Authors

Paul W Armstrong¹, Burkert Pieske², Christopher M O'Connor^{3

4}

Affiliations

¹ Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada.
² Charité University Medicine, German Heart Center, Berlin, Germany.
³ Duke Clinical Research Institute, Duke University, Durham, NC, USA.
⁴ Inova Heart and Vascular Institute, Falls Church, VA, USA.

PMID: 32086856
DOI: 10.1002/ejhf.1765

No abstract available

Publication types

Letter
Comment

MeSH terms

Heart Failure* / drug therapy
Heterocyclic Compounds, 2-Ring*
Humans
Pyrimidines
Stroke Volume

Substances

Heterocyclic Compounds, 2-Ring
Pyrimidines
vericiguat